CURRENT OPINION IN INFECTIOUS DISEASES

Scope & Guideline

Navigating Complexities in Infectious Disease Research

Introduction

Welcome to the CURRENT OPINION IN INFECTIOUS DISEASES information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CURRENT OPINION IN INFECTIOUS DISEASES, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0951-7375
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 2024
AbbreviationCURR OPIN INFECT DIS / Curr. Opin. Infect. Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

CURRENT OPINION IN INFECTIOUS DISEASES is dedicated to providing comprehensive insights into the evolving landscape of infectious diseases, focusing on contemporary challenges, diagnostic advancements, and innovative therapeutic strategies. The journal emphasizes multidisciplinary approaches and the integration of cutting-edge research to enhance clinical practice.
  1. Infectious Disease Management and Treatment:
    The journal covers a wide array of infectious diseases, detailing current treatment options, management strategies, and emerging therapies for various infections. This includes bacterial, viral, fungal, and parasitic infections, with a particular emphasis on multidrug-resistant pathogens.
  2. Diagnostic Innovations:
    A significant focus is placed on advancements in diagnostic methods, including molecular diagnostics, artificial intelligence, and machine learning applications that enhance the accuracy and speed of infectious disease diagnosis.
  3. Infection Prevention and Control:
    The journal addresses strategies and controversies in infection prevention, particularly in vulnerable populations such as immunocompromised patients, pregnant women, and the elderly, highlighting best practices and challenges in clinical settings.
  4. Epidemiological Insights:
    CURRENT OPINION IN INFECTIOUS DISEASES provides analyses on epidemiological trends and public health implications of infectious diseases, including the impact of global issues like climate change and pandemics on infection dynamics.
  5. Host-Pathogen Interactions:
    Research on the interactions between hosts and pathogens, including immune responses and the implications for treatment and prevention strategies, is a core area of focus, contributing to a deeper understanding of infection biology.
Recent publications in CURRENT OPINION IN INFECTIOUS DISEASES have revealed several emerging themes that reflect the current challenges and advancements in the field of infectious diseases. These trends indicate a dynamic response to global health crises and evolving scientific knowledge.
  1. Impact of COVID-19 on Infectious Disease Practices:
    The ongoing influence of the COVID-19 pandemic has led to a surge in research focused on its implications for infectious disease management, prevention strategies, and the long-term effects on patients, particularly those with comorbidities.
  2. Integration of Artificial Intelligence and Machine Learning:
    There is a notable increase in publications discussing the application of AI and machine learning in diagnostics, treatment planning, and infection control, highlighting the journal's commitment to embracing innovative technologies in healthcare.
  3. Focus on Vulnerable Populations:
    Emerging research emphasizes the challenges faced by vulnerable populations, such as the immunocompromised, pregnant women, and marginalized communities, reflecting a growing recognition of health disparities in infectious disease outcomes.
  4. Resilience Against Antimicrobial Resistance (AMR):
    Research addressing strategies to combat antimicrobial resistance, including novel therapeutics and stewardship programs, is gaining traction, underscoring the urgency of this global health threat.
  5. Exploration of the Microbiome's Role in Disease:
    An increasing number of studies are investigating the microbiome's impact on health and disease susceptibility, indicating a trend towards understanding complex host-pathogen interactions and their clinical implications.

Declining or Waning

As the field of infectious diseases evolves, certain themes and topics have shown a decline in publication frequency or prominence within the journal. This can reflect shifts in research priorities or the successful resolution of previously pressing issues.
  1. Traditional Antibiotic Stewardship Approaches:
    While antibiotic stewardship remains critical, there has been a noticeable decline in discussions surrounding traditional approaches, possibly due to the emergence of more innovative methods and technologies, such as machine learning and precision medicine.
  2. Basic Research in Non-Clinical Settings:
    There appears to be a waning focus on basic research that does not directly translate into clinical practice or public health policy, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Generalized Vaccination Strategies:
    The journal has shifted away from broad discussions of vaccination strategies in favor of more targeted analyses, particularly regarding specific populations or emerging infectious threats, suggesting a decline in interest in generalized vaccination discussions.

Similar Journals

Infectious Disease Reports

Connecting researchers to combat infectious challenges.
Publisher: MDPIISSN: Frequency: 6 issues/year

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

MIKROBIYOLOJI BULTENI

Illuminating the Pathways of Microbial Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

JOURNAL OF INFECTION

Driving Progress in the Fight Against Infectious Diseases
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

INTERVIROLOGY

Fostering knowledge in the fight against viral threats.
Publisher: KARGERISSN: 0300-5526Frequency: 6 issues/year

INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.

Infectious Microbes & Diseases

Empowering researchers in the fight against infectious diseases.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

Hepatitis Monthly

Empowering healthcare through cutting-edge research.
Publisher: BRIEFLANDISSN: 1735-143XFrequency: 12 issues/year

Hepatitis Monthly, published by BRIEFLAND in the Netherlands, is a pivotal journal in the fields of hepatology and infectious diseases. Established in 2007, it continues to make significant contributions to the understanding and management of hepatitis and related viral infections with a publication timeline extending through to 2024. Aiming to disseminate high-quality research, the journal serves as a forum for groundbreaking studies and innovations essential for healthcare professionals, researchers, and students alike. While it currently holds Q4 rankings in both hepatology and infectious disease categories, its ongoing commitment to addressing pressing health issues makes it an important resource in the academic community. Although it operates under a traditional access model, Hepatitis Monthly not only publishes original research articles, reviews, and case studies but also encourages the exchange of knowledge that helps shape future research directions and clinical practices. As it continues to explore the complexities surrounding viral hepatitis, this journal invites researchers to contribute to its mission of advancing scientific understanding and improving patient care.

Journal of Pediatric Infection

Illuminating the path to better pediatric infection management.
Publisher: AVES YAYINCILIK, IBRAHIM KARAISSN: 1307-1068Frequency: 4 issues/year

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.

Journal of Clinical Virology Plus

Fostering collaboration for impactful virology insights.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

Infectious Agents and Cancer

Exploring the vital links between pathogens and cancer progression.
Publisher: BMCISSN: 1750-9378Frequency: 1 issue/year

Infectious Agents and Cancer is a pivotal open access journal published by BMC, dedicated to advancing research at the intersection of infectious diseases and oncology. Since its inception in 2006, this journal has provided a platform for the exploration of the complex relationships between infectious agents and cancer development, aimed at researchers, healthcare professionals, and students alike. With a broad scope encompassing epidemiology and cancer research, the journal holds an impressive ranking in the Q3 quadrant for epidemiology, infectious diseases, and oncology in 2023, while also featuring in the Q4 category for cancer research. This distinguished journal not only contributes to the enrichment of scientific knowledge but also fosters collaborative efforts towards innovative solutions in the fight against cancer. Being part of the UK publishing landscape, the journal is accessible to a global audience, ensuring that vital research findings are disseminated widely to inform policy and practice in health sciences.

MYCOPATHOLOGIA

Exploring the intersection of agriculture and veterinary microbiology.
Publisher: SPRINGERISSN: 0301-486XFrequency: 6 issues/year

MYCOPATHOLOGIA, published by Springer in the Netherlands, stands as a pivotal journal in the fields of mycology, plant science, and veterinary microbiology. With its extensive history dating back to 1938, this journal has consistently contributed to the understanding of fungal pathogens and their impact on both agriculture and animal health. It currently holds impressive rankings in Scopus, including Q1 status in Agronomy and Crop Science, and Q2 rankings in Applied Microbiology and Biotechnology, demonstrating its influence and rigor in the scientific community. Researchers and professionals benefit from its curated, high-quality studies which address critical areas such as plant-pathogen interactions and veterinary mycology. While not open access, MYCOPATHOLOGIA emphasizes comprehensive research output and serves as a vital resource for advancing knowledge and fostering innovation in its disciplines. The journal remains committed to disseminating valuable insights that drive forward both academic inquiry and practical applications in related fields, ensuring its relevance and importance in contemporary research.